[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"influenza-virus\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:influenza-virus":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100576395","community---the-covid-19-immunity-study-100576395",false,"NCT06784739","COMMUNITY - the COVID-19 Immunity Study","COMMUNITY","Inclusion Criteria:\n\n* Health care workers: Employment at Danderyd hospital at time of enrollment\n* COVID-19 patients: Admitted to Danderyd Hospital with confirmed SARS-CoV-2 infection at time of enrollment\n\nExclusion Criteria:\n\n* No exclusion criteria",true,"ALL","18 Years",{"count":20,"type":21},5500,"ESTIMATED","OBSERVATIONAL","The principal aim of the COMMUNITY study is to investigate immune responses following SARS-CoV-2 infection and\u002For vaccination in healthcare workers and hospitalized COVID-19 patients. The study aims to enroll a total of 5,000 healthcare workers and 500 COVID-19 patients. All participants are enrolled at Danderyd Hospital in Stockholm, Sweden. Participants will be followed every four months with blood and mucosal sampling in addition to demographic and clinical data provided by the participants and from national registries.\n\nPrimary outcome:\n\n\\- Antibody responses in blood and mucosa following SARS-CoV-2 infection and\u002For vaccination\n\nSecondary outcomes:\n\n* Cellular immune responses following SARS-CoV-2 infection and\u002For vaccination\n* Antibody responses in blood and mucosa following following Influenza A\u002FB infection and\u002For vaccination\n* Antibody responses in blood and mucosa following following RSV A\u002FB infection\n\nBlood and mucosal samples are collected every 4 months and at tighter intervals in sub studies. PCR testing is conducted upon symptoms of respiratory infections and with regular intervals regardless of symptomatology in sub studies. Participants provide detailed demographic and clinical data through a smart phone application-based questionnaire. Data on infection and vaccination history is collected from national registries",[25,26,27,28],"COVID 19","Respiratory Synctial Virus","Influenza Virus","SARS-CoV-2 Virus",[30,31,32,33,34],"COVID-19","Mucosal immunity","Pandemic","Vaccination","Secretory IgA","RECRUITING","2025-01-16",{"date":38,"type":39},"2025-01-20","ACTUAL",{"date":41,"type":39},"2020-04-15",{"date":43,"type":21},"2027-04",{"name":45,"class":46},"Danderyd Hospital","OTHER",2]